At the Vanguard and Heart of the Life Science
Ecosystem™
NEW
YORK, June 22, 2022 /PRNewswire/ -- Alexandria
Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and
the first, longest-tenured and pioneering owner, operator and
developer uniquely focused on collaborative life science, agtech
and technology campuses in AAA innovation cluster locations, today
celebrates the grand opening of Alexandria LaunchLabs®
at Columbia, which was created in a strategic collaboration with
Columbia University. As the company's
second LaunchLabs site in New York
City, Alexandria LaunchLabs at Columbia builds upon the
success of the flagship LaunchLabs site at the Alexandria
Center® for Life Science – New
York City, which reached its fifth anniversary this month.
The grand opening event marks an important milestone for
the unique and leading life science startup
platform purpose-built to accelerate innovation and growth for
promising early-stage companies. With over 10,000 diseases known to
humankind and less than 10% currently addressable with therapies,
Alexandria LaunchLabs at Columbia is playing an essential role in
catalyzing the translation of scientific research emerging from
Columbia University and other leading
NYC academic and medical research institutions into treatments and
cures to help meet humanity's massive unmet medical need and
alleviate patient suffering.
"For years, there has been an explosion of new startup creation
emerging from Columbia's research
labs (over 25 new startups per year), as well as from the labs of
our fellow NYC research institutions," said Orin Herskowitz, executive director of Columbia
Technology Ventures. "The integration of the Alexandria LaunchLabs
platform into Columbia's campus
provides a further boost to the NYC entrepreneurial ecosystem,
Columbia's startups, other
New York City startups and the
city overall. We couldn't be more pleased to have the Alexandria
LaunchLabs platform on campus."
Alexandria led the pioneering
effort to create the NYC commercial life science cluster through
the development of the Alexandria Center for Life Science, the
city's first and only commercial life science campus. Since opening
this flagship campus in 2010, Alexandria has successfully led, catalyzed and
nurtured a collaborative ecosystem that coalesces translational
innovation, leading scientific and managerial talent and
sophisticated capital with world-renowned academic and medical
institutions to drive the discovery, development and
commercialization of groundbreaking therapies and cures that can
extend, improve and save patients' lives. Leveraging its position
as a key leader and collaborator in the life science ecosystem, the
company has profoundly contributed to the success of many of the
city's most promising life science companies. Intra-Cellular
Therapies, which has received FDA approval for the treatment of
bipolar depression and schizophrenia in adults, is a tremendous
example of an Alexandria tenant
that has taken scientific insights from the bench and successfully
translated them to enable the delivery of novel medicines to
patients around the world suffering from these intractable central
nervous system disorders.
"We are immensely proud to be a leader and first mover in the
catalyzation, growth and evolution of the New York City commercial life science
ecosystem and cluster, where we have amplified the value of our
mission-critical laboratory real estate through our strategic
venture activity and guidance, thought leadership and
ecosystem-building programs, as well as our innovative
proprietary offerings such as LaunchLabs," said Joel S. Marcus, executive chairman and founder
of Alexandria Real Estate Equities, Inc. and Alexandria Venture
Investments. "Embedding our proven LaunchLabs platform at
Columbia is crucial to advancing
transformative medicines for the benefit of society, and we are
honored to expand our longstanding relationship with Columbia, an exceptional institution that has
made rich contributions to human health, in this mission-critical
and meaningful endeavor."
"As LaunchLabs celebrates one year of operations at Columbia, we have diligently curated a stellar
group of member companies from across the local ecosystem that are
utilizing novel therapeutic and diagnostic platforms to address a
broad range of diseases, including difficult-to-treat cancers,
neurodegenerative diseases and autoimmune disorders, as well as
metabolic and rare genetic diseases," said Michael Norsen, principal of science and
technology at Alexandria Venture Investments and head of Alexandria
LaunchLabs at Columbia for
Alexandria Real Estate Equities, Inc. "The opportunity to
strategically expand our LaunchLabs platform in collaboration with
Columbia enhances our ability to
bolster life science entrepreneurship, nurture the city's most
promising biotech startups and continue to attract and retain top
talent within the local NYC ecosystem."
In addition to its grand opening event at the Alexandria
LaunchLabs at Columbia, today
Alexandria is convening its annual
New York City Life Science Innovation Showcase at the Alexandria
Center for Life Science – NYC. This showcase celebrates a curated
group of preeminent life science entrepreneurs and startups from
NYC's top academic and medical research institutions. The program
will include rapid-fire company pitches interspersed with panel
discussions featuring some of the city's most notable founders,
executives and venture investors, all with the common goal of
accelerating the translation of novel discoveries into biomedical
realities to address many of the most challenging diseases known to
humankind.
About Alexandria Real Estate Equities, Inc.
Alexandria
Real Estate Equities, Inc. (NYSE: ARE), an S&P 500®
urban office REIT, is the first, longest-tenured and pioneering
owner, operator and developer uniquely focused on collaborative
life science, agtech and technology campuses in AAA innovation
cluster locations, with an asset base in North America of 74.2 million SF as of
March 31, 2022. The asset base in
North America includes 41.9
million RSF of operating properties and 5.4 million RSF of Class A
properties undergoing construction, 10.4 million RSF of near-term
and intermediate-term development and redevelopment projects and
16.5 million SF of future development projects. Founded in 1994,
Alexandria pioneered this niche
and has since established a significant market presence in key
locations, including Greater
Boston, the San Francisco Bay
Area, New York City,
San Diego, Seattle, Maryland and Research Triangle. Alexandria has a longstanding and proven track
record of developing Class A properties clustered in urban life
science, agtech and technology campuses that provide our innovative
tenants with highly dynamic and collaborative environments that
enhance their ability to successfully recruit and retain
world-class talent and inspire productivity, efficiency, creativity
and success. Alexandria also
provides strategic capital to transformative life science, agtech
and technology companies through our venture capital platform. We
believe our unique business model and diligent underwriting ensure
a high-quality and diverse tenant base that results in higher
occupancy levels, longer lease terms, higher rental income, higher
returns and greater long-term asset value. For additional
information on Alexandria, please
visit www.are.com.
About Alexandria LaunchLabs
Alexandria LaunchLabs, created
by the pioneer of mission-critical Labspace® real
estate, is the premier life science startup platform purpose-built
to accelerate the growth of transformative early-stage companies,
empowering the advancement of groundbreaking discoveries within
Alexandria's thriving life science
ecosystems in New York City,
Cambridge, Research Triangle,
Seattle and Stanford Research
Park. Alexandria LaunchLabs is unmatched in equipping early-stage
life science companies with dedicated laboratory/office space and
core equipment, vital operational services, curated introductions
to our preeminent network, access to capital through Alexandria
Venture Investments and the Alexandria Seed Capital Platform and
expert support from our best-in-class teams — all developed to
provide our curated community of member companies with a scalable
path for growth. Alexandria LaunchLabs is currently accepting
applications for all locations. For more information, please visit
www.alexandrialaunchlabs.com.
Forward-Looking Statements
This press release
includes "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Such
forward-looking statements include, without limitation, statements
regarding the potential impacts of Alexandria LaunchLabs at
Columbia University on Alexandria's and its tenants' business,
continued growth, goals and ability to recruit and retain talent as
well as the impact on the broader life science industry. These
forward-looking statements are based on the company's present
intent, beliefs or expectations, but forward-looking statements are
not guaranteed to occur and may not occur. Actual results may
differ materially from those contained in or implied by the
company's forward-looking statements as a result of a variety of
factors, including, without limitation, the risks and uncertainties
detailed in its filings with the Securities and Exchange
Commission. All forward-looking statements are made as of the date
of this press release, and the company assumes no obligation to
update this information. For more discussion relating to risks and
uncertainties that could cause actual results to differ materially
from those anticipated in the company's forward-looking statements,
and risks and uncertainties to the company's business in general,
please refer to the company's filings with the Securities and
Exchange Commission, including its most recent annual report on
Form 10-K and any subsequently filed quarterly reports on Form
10-Q.
CONTACT: Sara Kabakoff, Vice
President – Communications, (626) 788‑5578,
skabakoff@are.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alexandria-real-estate-equities-inc-celebrates-the-grand-opening-of-alexandria-launchlabs-at-columbia-to-accelerate-the-commercialization-of-novel-translational-science-to-meet-significant-unmet-medical-needs-301572550.html
SOURCE Alexandria Real Estate Equities, Inc.